FI963674A0 - Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF) - Google Patents

Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF)

Info

Publication number
FI963674A0
FI963674A0 FI963674A FI963674A FI963674A0 FI 963674 A0 FI963674 A0 FI 963674A0 FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A0 FI963674 A0 FI 963674A0
Authority
FI
Finland
Prior art keywords
bdnf
recombinant dna
neurotrophic factor
derived neurotrophic
adenovirus encoding
Prior art date
Application number
FI963674A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI963674A (en
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI963674A publication Critical patent/FI963674A/en
Publication of FI963674A0 publication Critical patent/FI963674A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI963674A 1994-03-18 1996-09-17 Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF) FI963674A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (en) 1994-03-18 1994-03-18 Recombinant viruses, preparation and use in gene therapy.
PCT/FR1995/000250 WO1995025804A1 (en) 1994-03-18 1995-03-02 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)

Publications (2)

Publication Number Publication Date
FI963674A FI963674A (en) 1996-09-17
FI963674A0 true FI963674A0 (en) 1996-09-17

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963674A FI963674A0 (en) 1994-03-18 1996-09-17 Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF)

Country Status (12)

Country Link
EP (1) EP0750676A1 (en)
JP (1) JPH09510358A (en)
KR (1) KR970701784A (en)
AU (1) AU703793B2 (en)
CA (1) CA2184200A1 (en)
FI (1) FI963674A0 (en)
FR (1) FR2717496B1 (en)
IL (1) IL112992A0 (en)
MX (1) MX9603490A (en)
NO (1) NO963559L (en)
WO (1) WO1995025804A1 (en)
ZA (1) ZA952244B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (en) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
CA2408255A1 (en) * 2000-05-05 2001-11-15 Marie T. Filbin Methods for stimulating nervous system regeneration and repair by regulating arginase 1 and polyamine synthesis
US20210079050A1 (en) * 2018-02-20 2021-03-18 Carmel Haifa University Economic Corporation Ltd. Compositions and methods for delivery and expression of small inhibitory peptides and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE202939T1 (en) * 1991-07-10 2001-07-15 Regeneron Pharma METHOD FOR TREATING MOTOR NEURON DISEASES BY MEMBERS OF THE BDNF/NT-3/NGF FAMILY
US5733871A (en) * 1991-11-08 1998-03-31 The General Hospital Corporation Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1994003199A1 (en) * 1992-08-04 1994-02-17 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
JPH08501686A (en) * 1992-09-25 1996-02-27 ローン−プーラン・ロレ・ソシエテ・アノニム Adenovirus vector for transfer of foreign gene to cells in central nervous system, especially brain
FR2704234B1 (en) * 1993-04-22 1995-07-21 Centre Nat Rech Scient RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.

Also Published As

Publication number Publication date
FR2717496B1 (en) 1996-04-12
WO1995025804A1 (en) 1995-09-28
FI963674A (en) 1996-09-17
FR2717496A1 (en) 1995-09-22
AU1896295A (en) 1995-10-09
JPH09510358A (en) 1997-10-21
EP0750676A1 (en) 1997-01-02
KR970701784A (en) 1997-04-12
MX9603490A (en) 1997-03-29
NO963559L (en) 1996-08-26
CA2184200A1 (en) 1995-09-28
ZA952244B (en) 1996-01-16
IL112992A0 (en) 1995-06-29
AU703793B2 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
ATE191146T1 (en) STABILIZED, ALBUMIN-FREE, LOW SUGAR PREPARATION CONTAINING RECOMBINANT FACTOR VIII
GB2347930B (en) IGF-1 receptor interacting proteins (IIPs), genes coding therefor and uses thereof
EE04684B1 (en) Moraxella catarrhalis outer membrane protein-106pol peptide, gene sequence and its use
FI924091A0 (en) AUTHORIZATION PROTOCOL SOM FOERSIKTIGHETSHJAELPMELEL.
DE69714347D1 (en) Elevator system with group control
DE69828329D1 (en) Manually operated corkscrew with multiple support points
HK1033149A1 (en) Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use.
DE69310280D1 (en) Alumina, calcium oxide, yttria sealant composition
FI963674A0 (en) Recombinant DNA adenovirus encoding brain-derived neurotrophic factor (BDNF)
AU1381299A (en) Novel genes encoding transporter-like molecules
IT228551Y1 (en) COMPOSITE PANEL, PARTICULARLY SUITABLE FOR FORMWORKS AND FLOORS.
ATA1972000A (en) RECOMBINANTLY MADE INTESTINAL NPT2B POLYPEPTIDE
NO901434D0 (en) NEUROTROPHIC PEPTIDES.
EP0958304A4 (en) Nucleotide sequence encoding the cd33-like protein
DE59813562D1 (en) Pigment preparations for the inkjet process
DE69738977D1 (en) NEW FUSION PROTEIN, DAFUER ENCODING GENE, REBATE APPLICATION
NO20022542L (en) DNA encoding a new Ets polypeptide
HUP0103361A2 (en) Factor viii homologue nucleic acids, polypeptides, methods, uses
GB2311736B (en) Ultra-violet (u.v) bubble mix
FI884556A (en) RECOMBINANT PLASMID DNA PPR-IFN 1-13, SOM CODE FOER SYNTES AV MAENNISKANS FIBROBLAST-1-INTERFERON, FOERFARANDE FOER FRAMSTAELLNING DAERAV OCH E.COLI INNEHAOLLANDE DETTA.
ITPD970057A0 (en) TROLLEY FOR MAINSAIL
EP1251171A4 (en) Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality
SE9401043D0 (en) Ports (Pools), purification, circ., Heating
IL140030A0 (en) Polypeptides dna molecules encoding them
ZA972556B (en) Control for several lift groups with destination call control.

Legal Events

Date Code Title Description
MA Patent expired